Drug Trial Radar · NCT00050973
Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer
Last checked: Nov 20, 2026Latest source record: May 14, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
623
Actual
Start
Not stated
Primary completion
Nov 2004
Study completion Mar 2005
Sponsor
- Lead sponsor
- Eisai Inc.Eisai
- Sponsor type
- Industry
- First posted
- Jan 3, 2003
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study evaluates the use of Targretin capsules (bexarotene) in combination with standard chemotherapy for the treatment of metastatic Non-Small Cell Lung Cancer (NSCLC) in patients who have not yet received chemotherapy for their lung cancer.
Conditions
- Non-small Cell Lung Cancer
Interventions
bexaroteneDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
77 sites in 11 countries. Site status is shown where the registry gives one.
Brookwood Medical Center
Birmingham, Alabama
Southern Arizona VA Healthcare System
Tucson, Arizona
Arroyo Research Inc.
Pasadena, California
Desert Hematology-Oncology Medical Group, Inc.
Rancho Mirage, California
University of Florida
Gainsville, Florida
New Hope Cancer Center
Hudson, Florida
Veterans Affairs Medical Center
Miami, Florida
Bay Area Cancer Consultants
Palm Harbor, Florida
Northwest Medical Specialists
Arlington Heights, Illinois
Jayne Gurtler, M.D., APMC
Metairie, Louisiana
Louisiana State University Health Science Center
New Orleans, Louisiana
St. Joseph Mercy Oakland Hospital
Pontiac, Michigan
Capitol Comprehensive Cancer Care Clinic
Jefferson City, Missouri
SUNY Downstate Medical Center
Brooklyn, New York
VA Western New York Health Care System
Buffalo, New York
Hematology-Oncology Associates
Toledo, Ohio
Tariq Mahmood
Midwest City, Oklahoma
University Oncology & Hematology Associates
Chattanooga, Tennessee
Marshfield Medical Research Foundation
Marshfield, Wisconsin
Medical Associates Health Centers
Menomonee Falls, Wisconsin
Canberra Hospital
Garran, Australian Capital Territory, Australia
Port Macquarie Base Hospital
Port Macquarie, New South Wales, Australia
Southern Medical Daycare Centre
Wollongong, New South Wales, Australia
Burnside War Memorial Hospital
Toorak Gardens, South Australia, Australia
Queen Elizabeth Hospital
Woodville, South Australia, Australia
Royal Hobart Hospital
Hobart, Tasmania, Australia
Box Hill Hospital
Box Hill, Victoria, Australia
Border Medical Oncology
Wodonga, Victoria, Australia
Tom Baker Cancer Centre
Calgary, Alberta, Canada
Cancer Care Manitoba
Winnepeg, Manitoba, Canada
QEII Health Sciences Center
Halifax, Nova Scotia, Canada
Ottawa Regional Cancer Centre
Ottawa, Ontario, Canada
Nemocnice odd. Onkologie
České Budějovice, Czechia
Pneumologicka klinika 1. LF UK
Praha-6-Veleslavin, Czechia
Klinika pneumologie a hrudni chirurgie 3.LF
Praha-8, Czechia
Centre Hospitalier General de Belfort
Belfort, Cedex, France
Centre Hospitalier Francois Maillot
Briey, Cedex, France
Institut Jean Godinot
Reims, Cedex, France
Centre Hospitalier Intercommunal de la Haute-Saone
Vesoul, Cedex, France
6th Pneumonology Department, Sotiria Hospital for Diseases of the Chest
Athens, Greece
Showing 40 of 77 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.